These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27899073)

  • 1. Recommendations for the analysis of individually randomised controlled trials with clustering in one arm - a case of continuous outcomes.
    Flight L; Allison A; Dimairo M; Lee E; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2016 Nov; 16(1):165. PubMed ID: 27899073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapist effects in randomised controlled trials: what to do about them.
    Walters SJ
    J Clin Nurs; 2010 Apr; 19(7-8):1102-12. PubMed ID: 20492055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysing cluster randomised controlled trials using GLMM, GEE1, GEE2, and QIF: results from four case studies.
    Offorha BC; Walters SJ; Jacques RM
    BMC Med Res Methodol; 2023 Dec; 23(1):293. PubMed ID: 38093221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustering of continuous and binary outcomes at the general practice level in individually randomised studies in primary care - a review of 10 years of primary care trials.
    Stuart B; Becque T; Moore M; Little P
    BMC Med Res Methodol; 2020 Apr; 20(1):83. PubMed ID: 32293280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
    Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
    Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes.
    Vickerstaff V; Omar RZ; Ambler G
    BMC Med Res Methodol; 2019 Jun; 19(1):129. PubMed ID: 31226934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and analysis of clinical trials with clustering effects due to treatment.
    Roberts C; Roberts SA
    Clin Trials; 2005; 2(2):152-62. PubMed ID: 16279137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing clustering effects and learning effects in the design and analysis of multicentre randomised trials: a survey to establish current practice.
    Conroy EJ; Blazeby JM; Burnside G; Cook JA; Gamble C
    Trials; 2020 May; 21(1):433. PubMed ID: 32460815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing potential sources of clustering in individually randomised trials.
    Kahan BC; Morris TP
    BMC Med Res Methodol; 2013 Apr; 13():58. PubMed ID: 23590245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partially clustered designs for clinical trials: Unifying existing designs using consistent terminology.
    Lange KM; Kasza J; Sullivan TR; Yelland LN
    Clin Trials; 2023 Apr; 20(2):99-110. PubMed ID: 36628406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of standardised mean differences from randomised trials with treatment-related clustering associated with care providers.
    Walwyn R; Roberts C
    Stat Med; 2017 Mar; 36(7):1043-1067. PubMed ID: 27910117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new dependence parameter approach to improve the design of cluster randomized trials with binary outcomes.
    Crespi CM; Wong WK; Wu S
    Clin Trials; 2011 Dec; 8(6):687-98. PubMed ID: 22049087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing cluster composition in cluster randomised controlled trials: design and analysis considerations.
    Corrigan N; Bankart MJ; Gray LJ; Smith KL
    Trials; 2014 May; 15():184. PubMed ID: 24884591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures.
    Bell ML; McKenzie JE
    Psychooncology; 2013 Aug; 22(8):1738-47. PubMed ID: 23080401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.
    Mason AJ; Gomes M; Grieve R; Ulug P; Powell JT; Carpenter J
    Clin Trials; 2017 Aug; 14(4):357-367. PubMed ID: 28675302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing appropriate analysis methods for cluster randomised cross-over trials with a binary outcome.
    Morgan KE; Forbes AB; Keogh RH; Jairath V; Kahan BC
    Stat Med; 2017 Jan; 36(2):318-333. PubMed ID: 27680896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials.
    Kasza J; Hemming K; Hooper R; Matthews J; Forbes AB
    Stat Methods Med Res; 2019 Mar; 28(3):703-716. PubMed ID: 29027505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.